
Yashpal Singh Malik
Deputy Director General (Agricultural Education)Indian Council of Agricultural Research, Headquarters, New Delhi , India
Submitted
2020/06/16First Online
2020/12/29doi
10.18805/IJAR.B-4223Cite article - Prachi Upadhyay, N.S. Jadon, Priyanka Pandey, Jyotsana Bhatt, Ramanpreet Singh Sandhu, Deepti Bodh, Manjul Kandpal, Sara Kaushal. (2020). Chemotherapeutic Effects of Docetaxel and Gene Expression of Epidermal Growth Factor Receptor During Regression of Mammary Tumours in Canines. Indian Journal of Animal Research. 56(1): 72–77. doi: 10.18805/IJAR.B-4223
Background: In this study the chemotherapeutic effects of docetaxel and gene expression of epidermal growth factor receptor (EGFR) during regression of mammary tumour in canines were evaluated.
Methods: Sixteen dogs suffering from canine mammary tumour were randomly divided into two groups viz . I and II and subjected to Docetaxel @ 30mg/m 2 weekly, four consecutive cycles, (Group I) and surgical excision of tumour followed by chemotherapy with Docetaxel @ 30mg/m 2 weekly, four consecutive cycles, (Group II). The therapeutic efficacy was assessed by clinical, radiological, ultrasonography, haemato-biochemical and histopathological evaluation including gene expression profiling of EGFR using Real-time PCR analysis.
Result: On the basis of the above parameters studied it was concluded that combination of surgery and chemotherapy using docetaxel is an effective treatment for the regression of mammary tumour and can be used safely by the field veterinarian. Real-time PCR analysis also revealed down-regulation of EGFR gene in group II.
true
Distinguished scholars and subject experts committed to editorial excellence, scientific integrity and rigorous peer review.
View Full Board